Metraipolis › archive › dc_1a20ccdec3fa

Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease — Europe PMC PMID:41597459

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41597459
DOI
10.3390/medicina62010172
License (as archived)
solo-consultazione
Archived
2026-11-06T18:50:41.717Z
SHA-256 of the archived text
6e8cf6af30558d983123ca5846f25e45e8e37651d4098e43c8e45eb4fee14c9c
Stable URL of this page
https://metraipolis.com/documento/dc_1a20ccdec3fa

How to cite

Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease — Europe PMC PMID:41597459 — Europe PMC (en), https://europepmc.org/article/MED/41597459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1a20ccdec3fa (Metraipolis archive dc_1a20ccdec3fa, sha256 6e8cf6af30558d983123ca5846f25e45e8e37651d4098e43c8e45eb4fee14c9c)
BibTeX
@misc{dc1a20ccdec3fa,
  title = {Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease — Europe PMC PMID:41597459},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41597459},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1a20ccdec3fa; sha256 6e8cf6af30558d983123ca5846f25e45e8e37651d4098e43c8e45eb4fee14c9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41597459. Agents can read the archived copy with the MCP tool read_document.